Altamira Therapeutics income statement data for the quarter ended Jun 2025. This income statement covers 36 quarters of results from Jun 2013 through Jun 2025, standardized by Business Quant from the company’s SEC filings.
| Income StatementIncome Statement | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jan2023 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||
| Revenue | 0.40M | 0.42M | 0.39M | 0.36M | 0.51M | |||||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 4.79M | 4.39M | 4.34M | 3.10M | 2.05M | 1.72M | 35.09M | |||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 1.25M | 1.39M | 1.17M | 1.43M | 1.12M | 1.19M | 0.64M | |||||||||||||||||||||||||||||
| Restructuring CostsRestructuring | -0.53M | -0.33M | -0.10M | -0.11M | ||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 6.05M | 5.78M | 4.98M | 4.21M | 3.06M | 2.80M | 35.73M | |||||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -6.05M | -5.78M | -5.51M | -4.54M | -3.16M | -2.91M | -0.67M | |||||||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | -0.42M | -0.43M | -0.40M | -0.37M | -0.52M | -0.13M | -0.09M | |||||||||||||||||||||||||||||
| Gains (Losses) on Sale of Assets & InvestmentsGains on Sales | ||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | ||||||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.60M | 0.00M | 0.11M | -0.09M | 0.02M | -0.12M | 0.04M | |||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||
| EBIT | -6.05M | -5.78M | -5.51M | -4.54M | -3.16M | -2.91M | -0.67M | |||||||||||||||||||||||||||||
| EBT | -5.50M | -6.26M | -4.64M | -1.85M | -3.14M | -3.04M | -3.52M | |||||||||||||||||||||||||||||
| Tax ProvisionsTaxes | 0.01M | 0.01M | -0.04M | -0.01M | 0.01M | 0.01M | 0.14M | |||||||||||||||||||||||||||||
| Income After Tax | -5.51M | -6.27M | -4.60M | -1.84M | -3.15M | -3.05M | -3.66M | |||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -5.51M | -6.27M | -4.60M | -1.84M | -3.15M | -3.05M | -3.66M | |||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -5.49M | -6.25M | -4.65M | -1.84M | -3.13M | -3.03M | -3.71M | |||||||||||||||||||||||||||||
| Net Income Attributable to Noncontrolling InterestsNCI Net Income | 0.09M | |||||||||||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -5.49M | -6.25M | -4.65M | -1.84M | -3.13M | -3.03M | -3.71M | |||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -5.40M | -6.16M | -4.76M | -1.53M | -2.35M | -2.81M | -3.72M | |||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||
| Shares Outstanding | 0.01M | 0.01M | 0.02M | 0.02M | 0.03M | 0.03M | 0.05M | 0.05M | 0.05M | 0.49M | 0.49M | 2.83M | 2.83M | |||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.00M | 0.00M | 0.05M | 0.04M | 0.05M | 0.05M | 0.05M | 0.45M | 0.45M | |||||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.01M | 0.02M | 0.04M | 0.06M | 0.49M | 4.66M | ||||||||||||||||||||||||||||||
| EBITDA | -6.02M | -5.74M | -5.48M | -4.51M | -3.14M | -2.90M | -0.55M | |||||||||||||||||||||||||||||
| Interest ExpensesInt Expense | -0.42M | -0.43M | -0.40M | -0.37M | -0.52M | -0.13M | -0.09M |
Pull Altamira Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CYTOF&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CYTOF", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CYTOF&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();